Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Relapsed'

Relapsed published presentations and documents on DocSlides.

Recurrent Follicular Lymphoma

Recurrent Follicular Lymphoma

  • sherrill-nordquist
  • 37 Slides

With a Short First Remission:. How Aggressive Sho...

Novel

Novel

  • tatiana-dople
  • 28 Slides

Agents . for . Indolent . L. ymphoma . and . Mant...

Chronic lymphocytic leukemia,

Chronic lymphocytic leukemia,

  • natalia-silvester
  • 31 Slides

New agents timing?. Agne Paner, MD. Assistant pro...

M inimal

M inimal

  • jane-oiler
  • 36 Slides

R. esidual . D. isease in AML. Steven M. Kornblau...

How I treat relapsed childhood acute

How I treat relapsed childhood acute

  • trish-goza
  • 41 Slides

lymphoblastic leukemia.   . Franco Locatelli, Ma...

The Biology of Relapsed and Refractory Multiple Myeloma

The Biology of Relapsed and Refractory Multiple Myeloma

  • alexa-scheidler
  • 42 Slides

Topics. Current Treatment Options for Relapsed/Re...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

  • debby-jeon
  • 30 Slides

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

Relapsed or Relapsed/Refractory

Relapsed or Relapsed/Refractory

  • alexa-scheidler
  • 100 Slides

5 Multiple Myeloma SANDRA E. KURTIN, RN, MS, AOCN

Brentuximab Vedotin.

Brentuximab Vedotin.

  • luanne-stotts
  • 54 Slides

How and When Should it be Used in B and T cell Ly...

Relapsed and Refractory Myeloma

Relapsed and Refractory Myeloma

  • jane-oiler
  • 85 Slides

Ruben Niesvizky. Myeloma Center. Myelomacenter.or...

Improving Therapy Outcomes in Relapsed/Refractory

Improving Therapy Outcomes in Relapsed/Refractory

  • celsa-spraggs
  • 27 Slides

Hodgkin Lymphoma. Program Objectives. Brentuximab...

Pomalidomide

Pomalidomide

  • marina-yarberry
  • 25 Slides

therapy in relapsed/refractory myeloma: . A UK m...

Selecting Therapy for Relapsed/

Selecting Therapy for Relapsed/

  • tawny-fly
  • 26 Slides

Refractory Multiple Myeloma. Case #1. Monitoring ...

Personalized Therapy in Relapsed or Refractory CLL

Personalized Therapy in Relapsed or Refractory CLL

  • kittie-lecroy
  • 0 Slides

IWCLL Criteria for Treating CLL. Other Considerat...

Ibrutinib for Hairy Cell Leukemia

Ibrutinib for Hairy Cell Leukemia

  • pasty-toler
  • 0 Slides

. A Brief Update of an Ongoing Trial. Jeff Jones...

Ibrutinib : First-in Class Inhibitor of BTK

Ibrutinib : First-in Class Inhibitor of BTK

  • briana-ranney
  • 0 Slides

Forms a specific and irreversible bond with cyste...

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

  • conchita-marotz
  • 0 Slides

ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....

Relapsed/Refractory Follicular Lymphoma Conundrums

Relapsed/Refractory Follicular Lymphoma Conundrums

  • danika-pritchard
  • 0 Slides

This program will include a discussion of off-lab...

Activity Faculty Scott C. Howard, MD,

Activity Faculty Scott C. Howard, MD,

  • tatiana-dople
  • 0 Slides

MSc. University of Tennessee College of . Health ...

Case Discussion A 64-year old woman diagnosed with monoclonal

Case Discussion A 64-year old woman diagnosed with monoclonal

  • faustina-dinatale
  • 25 Slides

Case Discussion A 64-year old woman diagnosed wit...

Recurrent HL after Auto

Recurrent HL after Auto

  • karlyn-bohler
  • 17 Slides

T. ransplant . in CR on . B. rentuximab. . V. ed...

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

  • mitsue-stanley
  • 25 Slides

Bertrand Coiffier. Service d. ’. Hématologie. ...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

  • rayfantasy
  • 15 Slides

proceedings from the live CME event and may includ...

Please note, these are the

Please note, these are the

  • ryotheasy
  • 9 Slides

actual. . video-recorded proceedings from the . l...

A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and

A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and

  • scoopulachanel
  • 22 Slides

Myeloma. 1. Safety and Efficacy of Daratumumab wit...

Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas

Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas

  • botgreat
  • 15 Slides

Lisocabtagene. . Maraleucel. in Relapsed/Refract...

CAR-T Therapy in non-Hodgkin lymphomas

CAR-T Therapy in non-Hodgkin lymphomas

  • natalie
  • 23 Slides

Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...

Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell

Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell

  • sylvia
  • 1 Slides

Lymphoma and Response to Treatment Strategies . IN...

x0000x0000 xAttxachexd xBottxom xBBoxx

x0000x0000 xAttxachexd xBottxom xBBoxx

  • evans
  • 37 Slides

Chimeric Antigen Receptor Tcell TherapyClinical Gu...

Relapse in Chronic Myeloid

Relapse in Chronic Myeloid

  • ella
  • 36 Slides

A Guide for A relapse is the return of leukaemia ...

stanbul Med J 2019 201 358

stanbul Med J 2019 201 358

  • emily
  • 4 Slides

35 ÖZ Pes ekinovarus (PEV) sekellerine ve nüksl...

Understanding Lymphoma Series

Understanding Lymphoma Series

  • evans
  • 4 Slides

Helpline: 800 500 9976 | helpline@lymphoma.org U...

Supervisor: VS 高志平

Supervisor: VS 高志平

  • jovita
  • 27 Slides

Reporter: R4 . 張妙而. Introduction. . Mutatio...

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

  • willow
  • 15 Slides

Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...

Aktuelle Therapieempfehlungen beim Multiplen

Aktuelle Therapieempfehlungen beim Multiplen

  • brown
  • 57 Slides

Myelom. Heinz . Gisslinger. Medizinische Universit...

AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki

AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki

  • cesar673
  • 1 Slides

+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...

SWAG Protocols update March 2024

SWAG Protocols update March 2024

  • nehemiah176
  • 13 Slides

Kate Gregory. Lead Pharmacist for SWAG Protocols â...

Copyright © 2024 DocSlides. All Rights Reserved